Funded Tech Companies

Third Arc Bio

Third Arc Bio, based in Boston, has financial backing from AbbVie Biotech Ventures, BVF Partners and Hillhouse Capital Group.

Company Overview

Contact Information

Company Background Information

Overview

Our mission is to deliver transformational therapies for solid tumors and I&I diseases in the form of multifunctional antibodies that create immune synapses to precisely activate or inhibit T cells. We have a world class team with a proven track record of success, which positions us well to advance the next generation of highly innovative medicines that redefine the standard-of-care.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/23/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Peter Lebowitz

        

Chief Operating Officer

Joseph Erhardt

        

Chief Scientific Officer

Sanjaya Singh

        

VP - Bus. Development

Debi Watson

        

Company Investors

• AbbVie Biotech Ventures
• BVF Partners
• Hillhouse Capital Group
• Omega Funds
• Foresite Capital
• Logos Capital
• Vida Ventures
• Marshall Wace
• Cormorant Asset Management
• Goldman Sachs
• T. Rowe Price
• Janus Henderson Investors

Browse more funded tech companies:

Thiozen | Third Eye Health

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary